TheProfitWatch

CVAC - CureVac N.V. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.45 -0.05 (-0.92%) --- --- --- 0.0 (0.0%) 0.03 (0.56%) --- 0.0 (0.0%)

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

Category: /stock/categories/na
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
55.56
VWAP:
5.4
RVol:
0.84

Events

Period Kind Movement Occurred At

Related News